There are several numbers of lawsuits filed by plaintiffs against the manufacturers of IVC filter alleging that medical devices have design defects and were not properly tested before going to market. Lawsuits were being filed across America with claims that the IVC filters caused harm and even death in some cases. The devices have been utilized since 1979, where initially 2,000 people utilized IVC filters to combat the risk of pulmonary embolism. In 2007, about 167,000 IVC filters were being used to trap clots, and data suggests that the number of users has continued to increase in recent years.
A woman from Florida was implanted with the Meridian Vena Cava Filter. Recently the plaintiff filed a personal injury and defective product liability lawsuit against the manufacturer C.R Bard. According to the woman the Meridian blood clot filter made by C.R. Bard injured her internal organs. In September of 2011, Juliette Boyd was implanted with a Meridian IVC filter and after few months from implantation the device injured her internal organs. The lawsuit was filed by Juliette Boyd on August 19 in the U.S. District Court for Arizona under the case no. 2:16-CV-02791. She accuses C.R. Bard of negligence for selling a defective medical device, failing to warn about side effects, and concealing safety risks.
The lawsuit of Juliette Boyd is represented by Ben C. Martin of the Law Offices of Ben C. Martin in Dallas; Texas. The case was centralized in a Multi-District Litigation (MDL No. 2641) where at least 810 lawsuits are pending against C.R. Bard. Another 800 lawsuits are pending in a similar litigation against Cook Medical. The lawsuits claim that manufacturers failed to warn the general public about the potential health risks associated with the device.
Recent reviews of vena cava filters have demonstrated a wide variety of complications, both short and long term, mortality attributed directly to placement or presence of a vena cava filter is extremely rare. Meridian is a temporary filter that is implanted in the inferior vena cava (IVC). It traps a blood clot before it can reach the lungs. The trouble is that the Meridian is very reciprocal to other IVC filters made by C.R. Bard including the G2 and Recovery which have been linked to a 12% fracture risk in recent studies.
Serious complications such as caval perforation, caval thrombosis, filter fracture and fragment embolization, intracardiac migration, cardiac perforation, cardiac tamponade, and death have been reported in patients who have been implanted with IVC filters. Many of these complications occurred with long-term (greater than 30 days) filter implantation. The FDA safety communication recommends removal of the IVC filter between 29 and 54 days after implantation.
Manufacturers of medical devices owe a duty to patients to produce safe and effective products. This requires that manufacturers test their products for any defects prior to introducing them to the market. The lawsuits from several states throughout the America accuses the manufacturers which include negligence strict liability for design defect, strict liability for manufacturing defect, strict liability for failure to warn, and breach of warranty.